Tipifarnib | Interleukin Related interleukin-related.com

Product Name :
Tipifarnib

Search keywords :
Tipifarnib

drugId :
null

Target Vo:
Protein farnesyltransferase

Target Vo Short Name :
Ftase

Moa_Name:
Protein farnesyltransferase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Johnson & Johnson

Active Company_Name :
Kura Oncology Inc

Active Indication_Name:
Lymphoma, Non-Hodgkin

In Active Indication_Name:
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
STAT5a Antibody
Alkaline Phosphatase Antibody
CD45 Antibody (YA533): CD45 Antibody (YA533) is a non-conjugated and Rabbit origined monoclonal antibody about 147 kDa., targeting to CD45. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts